Berlex' Angeliq Approved, Will Launch In Mid-2006
This article was originally published in The Pink Sheet Daily
Executive Summary
The hormone therapy launch will be delayed to allow for physician education and to give the company time to consider internal resource issues as well as near-term pipeline opportunities, Berlex said.